Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2111815rdf:typepubmed:Citationlld:pubmed
pubmed-article:2111815lifeskim:mentionsumls-concept:C0013729lld:lifeskim
pubmed-article:2111815lifeskim:mentionsumls-concept:C0001480lld:lifeskim
pubmed-article:2111815lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:2111815lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:2111815lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:2111815lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:2111815pubmed:issue16lld:pubmed
pubmed-article:2111815pubmed:dateCreated1990-7-2lld:pubmed
pubmed-article:2111815pubmed:abstractTextEukaryotic initiation factor 2 (eIF-2) is shown to bind ATP with high affinity. Binding of ATP to eIF-2 induces loss of the ability to form a ternary complex with Met-tRNAf and GTP, while still allowing, and even stimulating, the binding of mRNA. Ternary complex formation between eIF-2, GTP, and Met-tRNAf is inhibited effectively by ATP, but not by CTP or UTP. Hydrolysis of ATP is not required for inhibition, for adenyl-5'-yl imidodiphosphate (AMP-PNP), a nonhydrolyzable analogue of ATP, is as active an inhibitor; adenosine 5'-O-(thiotriphosphate) (ATP gamma S) inhibits far more weakly. Ternary complex formation is inhibited effectively by ATP, dATP, or ADP, but not by AMP and adenosine. Hence, the gamma-phosphate of ATP and its 3'-OH group are not required for inhibition, but the beta-phosphate is indispensible. Specific complex formation between ATP and eIF-2 is shown 1) by effective retention of Met-tRNAf- and mRNA-binding activities on ATP-agarose and by the ability of free ATP, but not GTP, CTP, or UTP, to effect elution of eIF-2 from this substrate; 2) by eIF-2-dependent retention of [alpha-32P]ATP or dATP on nitrocellulose filters and its inhibition by excess ATP, but not by GTP, CTP, or UTP. Upon elution from ATP-agarose by high salt concentrations, eIF-2 recovers its ability to form a ternary complex with Met-tRNAf and GTP. ATP-induced inhibition of ternary complex formation is relieved by excess Met-tRNAf, but not by excess GTP or guanyl-5'-yl imidodiphosphate (GMP-PNP). Thus, ATP does not act by inhibiting binding of GTP to eIF-2. Instead, ATP causes Met-tRNAf in ternary complex to dissociate from eIF-2. Conversely, affinity of eIF-2 for ATP is high in the absence of GTP and Met-tRNAf (Kd less than or equal to 10(-12) M), but decreases greatly in conditions of ternary complex formation. These results support the concept that eIF-2 assumes distinct conformations for ternary complex formation and for binding of mRNA, and that these are affected differently by ATP. Interaction of ATP with an eIF-2 molecule in ternary complex with Met-tRNAf and GTP promotes displacement of Met-tRNAf from eIF-2, inducing a state favorable for binding of mRNA. ATP may thus regulate the dual binding activities of eIF-2 during initiation of translation.lld:pubmed
pubmed-article:2111815pubmed:languageenglld:pubmed
pubmed-article:2111815pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2111815pubmed:citationSubsetIMlld:pubmed
pubmed-article:2111815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2111815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2111815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2111815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2111815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2111815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2111815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2111815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2111815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2111815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2111815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2111815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2111815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2111815pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2111815pubmed:statusMEDLINElld:pubmed
pubmed-article:2111815pubmed:monthJunlld:pubmed
pubmed-article:2111815pubmed:issn0021-9258lld:pubmed
pubmed-article:2111815pubmed:authorpubmed-author:KaempferRRlld:pubmed
pubmed-article:2111815pubmed:authorpubmed-author:BanaiYYlld:pubmed
pubmed-article:2111815pubmed:authorpubmed-author:GonskaJJlld:pubmed
pubmed-article:2111815pubmed:authorpubmed-author:HararyRRlld:pubmed
pubmed-article:2111815pubmed:authorpubmed-author:LebendikerM...lld:pubmed
pubmed-article:2111815pubmed:issnTypePrintlld:pubmed
pubmed-article:2111815pubmed:day5lld:pubmed
pubmed-article:2111815pubmed:volume265lld:pubmed
pubmed-article:2111815pubmed:ownerNLMlld:pubmed
pubmed-article:2111815pubmed:authorsCompleteYlld:pubmed
pubmed-article:2111815pubmed:pagination9083-9lld:pubmed
pubmed-article:2111815pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2111815pubmed:meshHeadingpubmed-meshheading:2111815-...lld:pubmed
pubmed-article:2111815pubmed:meshHeadingpubmed-meshheading:2111815-...lld:pubmed
pubmed-article:2111815pubmed:meshHeadingpubmed-meshheading:2111815-...lld:pubmed
pubmed-article:2111815pubmed:meshHeadingpubmed-meshheading:2111815-...lld:pubmed
pubmed-article:2111815pubmed:meshHeadingpubmed-meshheading:2111815-...lld:pubmed
pubmed-article:2111815pubmed:meshHeadingpubmed-meshheading:2111815-...lld:pubmed
pubmed-article:2111815pubmed:meshHeadingpubmed-meshheading:2111815-...lld:pubmed
pubmed-article:2111815pubmed:meshHeadingpubmed-meshheading:2111815-...lld:pubmed
pubmed-article:2111815pubmed:meshHeadingpubmed-meshheading:2111815-...lld:pubmed
pubmed-article:2111815pubmed:meshHeadingpubmed-meshheading:2111815-...lld:pubmed
pubmed-article:2111815pubmed:meshHeadingpubmed-meshheading:2111815-...lld:pubmed
pubmed-article:2111815pubmed:meshHeadingpubmed-meshheading:2111815-...lld:pubmed
pubmed-article:2111815pubmed:meshHeadingpubmed-meshheading:2111815-...lld:pubmed
pubmed-article:2111815pubmed:meshHeadingpubmed-meshheading:2111815-...lld:pubmed
pubmed-article:2111815pubmed:meshHeadingpubmed-meshheading:2111815-...lld:pubmed
pubmed-article:2111815pubmed:meshHeadingpubmed-meshheading:2111815-...lld:pubmed
pubmed-article:2111815pubmed:meshHeadingpubmed-meshheading:2111815-...lld:pubmed
pubmed-article:2111815pubmed:meshHeadingpubmed-meshheading:2111815-...lld:pubmed
pubmed-article:2111815pubmed:year1990lld:pubmed
pubmed-article:2111815pubmed:articleTitleBinding of ATP to eukaryotic initiation factor 2. Differential modulation of mRNA-binding activity and GTP-dependent binding of methionyl-tRNAMetf.lld:pubmed
pubmed-article:2111815pubmed:affiliationDepartment of Molecular Virology, Hebrew University-Hadassah Medical School, Jerusalem, Israel.lld:pubmed
pubmed-article:2111815pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2111815pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2111815lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2111815lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2111815lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2111815lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2111815lld:pubmed